Skip to content

David Glowacki

2 papers in the library · publishing 2023

Papers

VR models of death and psychedelics: An un-collapsed high-entropy aesthetic paradigm for design beyond day-to-day phenomenology

August 31, 2023 David Glowacki preprint

Near-death experiences (NDEs) and psychedelic drug experiences (YDEs) both dissolve ordinary space-time distinctions and foster a sense of unity, and they can reduce death anxiety. The authors previously showed that multi-person virtual reality experiences (VREs) using a 'numadelic' aesthetic—representing bodies as light energy rather than material objects—produce psychometric results similar to YDEs. This article explains the aesthetic's origins in NDE accounts and proposes a theoretical framework based on predictive coding and physics concepts. The framework has two axes: 'structural specificity' and 'symbolic rigidity'. Most photorealistic VREs have high values on both, collapsing imaginative potential into a low-entropy space. Numadelic aesthetics, with low structural specificity and low symbolic rigidity, create an expansive high-entropy space for endogenous insights, explaining previous experimental findings and suggesting ways to model NDEs to address death anxiety.

Observational cohort study of a group-based VR program to improve mental health and wellbeing in people with life-threatening illnesses

Joe Hardy, Hannes Kettner, David Glowacki et al. preprint

A group-based virtual reality program called Clear Light, delivered at home over three weeks, improved anxiety, depression, and wellbeing in people with life-threatening illnesses. The program included multi-user VR experiences, video calls, and text chats designed to elicit self-transcendent experiences similar to psychedelics. In a small observational study of 15 participants, moderate improvements were seen in anxiety, depression, wellbeing, demoralization, connectedness, and spiritual wellbeing. The intervention was well-tolerated. The findings suggest potential benefits but are limited by the lack of a comparison group, indicating the need for randomized controlled trials.